metabolomics in myeloma
Published 2 years ago • 64 plays • Length 3:09Download video MP4
Download video MP3
Similar videos
-
2:06
the importance of proteomic analysis in myeloma and future outlooks
-
0:59
defining the origins of multiple myeloma
-
2:44
myeloma qol through induction and maintenance
-
1:12
altered metabolism in multiple myeloma
-
12:26
treating ultra high risk myeloma patients in a unique uk study | martin kaiser, md | ash 2021
-
1:44
the role of belantamab mafodotin in multiple myeloma: the dreamm-7 and dreamm-8 trials
-
3:15
what is the best diet for myeloma patients to build a strong immune system?
-
1:11
advances that have been made in the molecular characterization of multiple myeloma
-
2:46
managing patients with high-risk myeloma
-
1:16
the evolving use of selinexor in multiple myeloma
-
1:01
car-t: myeloma toxicities
-
2:36
a multi-omic study to improve the diagnosis of multiple myeloma
-
1:46
insights into mass spectrometry-based proteomics in multiple myeloma research
-
3:00
current & emerging biomarkers in multiple myeloma
-
1:53
the future of multiple myeloma treatment
-
1:28
evaluating next-generation immunotherapies in earlier lines of treatment in multiple myeloma
-
1:02
dreamm-3: safety of belantamab mafodotin versus pom/dex in patients with r/r myeloma
-
1:26
emerging monoclonal antibodies for the treatment of multiple myeloma
-
1:24
highlights from the 2016 european multiple myeloma academy (emma) and overview of emma 2017
-
2:11
overview and rationale for practical workshops at the 2016 european multiple myeloma academy (emma)
-
1:38
the genomic definition of high-risk myeloma